deoxycytidine has been researched along with Hodgkin Disease in 106 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (4.72) | 18.7374 |
| 1990's | 2 (1.89) | 18.2507 |
| 2000's | 41 (38.68) | 29.6817 |
| 2010's | 49 (46.23) | 24.3611 |
| 2020's | 9 (8.49) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Cai, QQ; Huang, H; Huang, HQ; Li, ZM; Liu, PP; Ma, SY; Su, N; Wang, JN; Xia, Y; Xia, ZJ; Zhang, YC | 1 |
| Baker, K; Buhtoiarov, IN; Bush, R; Cole, PD; Kelly, KM; Mba, NI; McCarten, KM; Metzger, ML; Pei, Q; Santos, CDL | 1 |
| Arslan, O; Gokgoz, Z; Gokmen, A; Ilhan, O; Okcu, MK; Ozan, U; Ozcan, M; Sahin, U; Soydan, E | 1 |
| Cao, L; Ding, K; Fan, L; Li, J; Liu, H; Ma, J; Peng, H; Shi, W; Wang, H; Wu, W; Yang, H; Zhao, X; Zhu, H | 1 |
| Davis, JH; Deyell, RJ; Douglas, K; Gershony, S; Marr, K; Nadel, H; Ronsley, R; Strahlendorf, C | 1 |
| Anastasia, A; Annechini, G; Bonfichi, M; Carlo-Stella, C; Castagna, L; Di Renzo, N; Giordano, L; Gotti, M; Liberati, AM; Luminari, S; Mazza, R; Merli, F; Peli, A; Pulsoni, A; Re, A; Ricci, F; Santoro, A; Zanni, M; Zilioli, VR | 1 |
| Altuntaş, F; Bakırtaş, M; Başçı, S; Batgi, H; Dal, MS; Darçın, T; İskender, D; Kızıl Çakar, M; Merdin, A; Şahin, D; Tetik, A; Uncu Ulu, B; Yiğenoğlu, TN; Yıldız, J | 1 |
| Abubakar, M; Jan, MRU; Saeed, H; Wali, RM | 1 |
| Li, J; Liu, Z; Mi, M; Wang, Y; Zhang, C; Zhang, L | 1 |
| Galvez-Silva, J; Hernandez, F; Liu, D; Maher, OM; Nieto, Y; Park, M; Tewari, P | 1 |
| Ahmed, S; Alousi, A; Anderlini, P; Andersson, BS; Champlin, R; Dabaja, B; Fanale, M; Gulbis, A; Hosing, C; Jones, RB; Kebriaei, P; Ma, J; Milgrom, S; Myers, A; Nieto, Y; Oki, Y; Pinnix, C; Popat, U; Qazilbash, M; Shpall, EJ; Thall, PF; Timmons, M; Valdez, BC | 1 |
| Chiappella, A; Vitolo, U | 1 |
| Blaney, SM; Bush, R; Cole, PD; Drachtman, RA; Horton, TM; Kelly, KM; McCarten, KM; Metzger, ML; Pei, Q; Spira, M; Weigel, BJ | 1 |
| Abuelgasim, KA; Alahmari, B; Alaskar, A; Alhejazi, A; Ali, O; Alsharhan, Y; Alzahrani, M; Damlaj, M; Gmati, G; Hommady, M; Khairi, M; Masuadi, EM; Salama, H | 1 |
| Dhanushkodi, M; Ganesan, P; Ganesan, TS; Joel, A; Kannan, K; Mehra, N; Perumal Kalayarasi, J; Radhakrishnan, V; Sagar, TG | 1 |
| Dua, V; Goyal, H | 1 |
| Bajpayee, A; Chaudhary, RK; Dubey, A; Verma, A | 1 |
| Ahmad, S; Khattak, J; Naqi, N; Shah, I | 1 |
| Barton, S; Chau, I; Chua, S; Cunningham, D; Dearden, C; Ethel, M; Hawkes, EA; Horwich, A; Peckitt, C; Potter, M; Wotherspoon, A | 1 |
| Bessler, M; Engert, A; Hansen, HP; Henke, A; Klein, JM; Reiners, KS; Sauer, M; von Strandmann, EP | 1 |
| Chen, YH; Marcus, KJ; Michaelson, EM; Ng, AK; Silver, B; Stevenson, MA; Tishler, RB | 1 |
| Kato, K | 1 |
| Dong, M; Gui, L; He, X; Liu, P; Qin, Y; Shi, Y; Yang, J; Yang, S; Zhang, C; Zhou, S | 1 |
| Amorin, S; Brice, P; Deau, B; Guillermin, Y; Harel, S; Lebras, L; Michallet, AS; Reynes, C; Salles, G; Subtil, F | 1 |
| Buchbinder, N; Jaffray, M; Lutun, A; Piquenot, JM; Schneider, P; Vannier, JP | 1 |
| Ahmed, S; Alousi, A; Anderlini, P; Andersson, BS; Bashir, Q; Champlin, R; Dabaja, B; Fanale, M; Gulbis, A; Hagemeister, F; Hosing, C; Jones, RB; Liu, Y; Nieto, Y; Oki, Y; Pinnix, C; Popat, U; Qazilbash, M; Shah, N; Shpall, EJ; Thall, PF; Valdez, BC | 1 |
| Li, H; Liu, H; Qiu, L; Xiong, W; Yi, S; Zou, D | 1 |
| Anastasia, A; Angelucci, E; Annechini, G; Balzarotti, M; Bonfichi, M; Botto, B; Brusamolino, E; Carella, AM; Congiu, A; Giordano, L; Gotti, M; Magagnoli, M; Massidda, S; Mazza, R; Merli, F; Murru, R; Re, A; Rodari, M; Russo, E; Salvi, F; Santoro, A; Spina, M; Stelitano, C; Vitolo, U; Zilioli, VR | 1 |
| Alousi, AM; Anderlini, P; Champlin, RE; Fanale, MA; Hagemeister, FB; Hosing, CM; Khouri, IF; Ledesma, C; Neelapu, S; Nieto, Y; Oki, Y; Plair, T; Popat, UR; Romaguera, JE; Saliba, RM; Shpall, EJ; Younes, A | 1 |
| Anderlini, P; Cheah, CY; Chihara, D; Fanale, MA; Fayad, LE; Fowler, NH; Hagemeister, FB; Horowitz, S; Nastoupil, LJ; Neelapu, SS; Nieto, Y; Oki, Y; Rodriguez, MA; Romaguera, JE; Samaniego, F; Sevin, A; Turturro, F; Wang, M; Westin, JR; Zhou, S | 1 |
| Connors, JM; Gascoyne, RD; Hitz, F; Hoskins, P; Klasa, R; Moccia, AA; Power, MM; Savage, KJ; Sehn, LH; Shenkier, T; Shepherd, JD; Slack, GW; Song, KW | 1 |
| Anastasia, A; Annechini, G; Bonfichi, M; Carlo-Stella, C; Castagna, L; Di Renzo, N; Giordano, L; Gotti, M; Liberati, AM; Luminari, S; Mazza, R; Merli, F; Peli, A; Pulsoni, A; Re, A; Salvi, F; Santoro, A; Zilioli, VR | 1 |
| Guru Murthy, GS; Hamadani, M; Jethava, Y | 1 |
| Bouabdallah, K; Brice, P; Carde, P; Chaoui, D; Decaudin, D; Diviné, M; Fermé, C; Fitoussi, O; Gabarre, J; Pacquement, H; Salhi, R; Soussain, C; Validire, P; Zanni, M | 1 |
| Bartlett, NL; Cashen, AF | 1 |
| Akyürek, N; Benekli, M; Büyükberber, S; Coşkun, U; Demirci, U; Oztürk, B; Tonyali, O; Yildiz, R; Yilmaz, G | 1 |
| Chen, L; Cole, PD; de Alarcon, PA; Drachtman, RA; Schwartz, CL; Trippett, TM | 1 |
| Ding, L; Duan, LN; Liu, J; Wang, HX; Wang, ZD; Xue, M; Yan, HM; Zhu, L | 1 |
| Bulusu, R; Camilleri, D; Follows, G; Marcus, R; Raj, S; Stafford, G; Todd, T; Williams, M | 1 |
| Böll, B; Borchmann, P; Engert, A; Gossmann, A; Reiners, KS; von Strandmann, EP | 1 |
| Konífrová, E; Móciková, H; Stríteský, J | 1 |
| García-Sanz, R; González-López, TJ; Graciani, IF; Hermida, G; San Miguel, JF; Vázquez, L | 1 |
| Chang, PY; Chen, JH; Yao, NS | 1 |
| Arai, S; Blume, KG; Horning, SJ; Johnston, LJ; Laport, GG; Lavori, PW; Letsinger, R; Lowsky, R; Miklos, DB; Negrin, RS; Shizuru, JA; Weng, WK; Wong, RM | 1 |
| Bollard, CM; Cruz, CR; Foster, AE; Heslop, HE; Ku, S; Leen, AM; Lu, A; Rooney, CM; Rousseau, A; Shafer, JA | 1 |
| Bartlett, NL; Blum, KA; Byrd, JC; Cheson, BD; Hsi, ED; Johnson, JL; Jung, SH; Lin, TS; Lucas, DM | 1 |
| Dougherty, DW; Friedberg, JW | 1 |
| Alarcon, Pd; Chen, L; Cole, PD; Drachtman, RA; McCarten, KM; Schwartz, CL; Trippett, TM | 1 |
| Armand, P; Di Salvo, D; Hwang, DG; Kelly, PJ; Nishino, M; O'Regan, KN | 1 |
| Akı, ŞZ; Özkurt, ZN; Sucak, GT; Suyanı, E; Yağcı, M; Yeğin, ZA | 1 |
| Bartlett, NL; Canellos, GP; Cheson, BD; Hall, NC; Hsi, ED; Johnson, JL; Jung, SH; Juweid, ME; Kostakoglu, L; LaCasce, AS; Schöder, H; Schwartz, LH; Straus, DJ; Takvorian, RW | 1 |
| Dimitrova, L; Ehlers, A; Hummel, M; Joosten, M; Lenze, D; Leser, U; Oker, E; Paul, U; Seitz, V; Sommerfeld, A; Stein, H; Thomas, PE; Zimmermann, K | 1 |
| Straus, DJ | 1 |
| Bollard, CM; Buglio, D; Derenzini, E; Illés, A; Ji, Y; Jóna, A; Khaskhely, N; Medeiros, LJ; Shafer, JA; Younes, A | 1 |
| Acholonu, S; Alousi, AM; Anderlini, P; Champlin, RE; Chancoco, C; Ciurea, S; Fanale, MA; Hosing, CM; Khouri, IF; Ledesma, C; Nieto, Y; Popat, UR; Saliba, RM; Shpall, EJ; Valverde, R; Younes, A | 1 |
| Böll, B; Borchmann, P; Bredenfeld, H; Eich, HT; Eichenauer, DA; Engert, A; Fuchs, M; Geissler, M; Görgen, H; Graeven, U; Halbsguth, T; Keller, U; Kremers, S; Markova, J; Soekler, M; Trenn, G; von Tresckow, B | 1 |
| Kreitman, RJ; Pastan, I; Singh, R; Zhang, Y | 1 |
| Botteri, E; Calabrese, L; Cocorocchio, E; Martinelli, G; Peccatori, F; Piperno, G; Preda, L; Travaini, L; Vanazzi, A | 1 |
| Aznar Oroval, E; García-Lozano, T; Juan Bañón, JL; Lorente Alegre, P | 1 |
| Loke, MM; Mann, S; Stellman, A | 1 |
| Casini, M; Cavattoni, IM; Cortelazzo, S; Deola, S; Farsad, M; Mian, M; Pescosta, N | 1 |
| Czyz, A; Dytfeld, D; Gil, L; Hellmann, A; Knopinska-Posluszny, W; Komarnicki, M; Lojko-Dankowska, A; Nowicki, A; Romejko-Jarosinska, J; Walewski, J | 1 |
| Alousi, A; Anderlini, P; Andersson, B; Bashir, Q; Champlin, R; Hosing, C; Jones, RB; Kebriaei, P; Khouri, I; Liu, P; Nieto, Y; Parmar, S; Popat, U; Qazilbash, M; Rondon, G; Shah, N; Shpall, EJ; Valdez, B | 1 |
| Aspillaga M, A; Buttinghausen, V; Chandía C, M; Orellana, M | 1 |
| Bai, B; Bu, Q; Cai, QC; Cai, QQ; Gao, Y; Guo, Y; Huang, HQ; Lin, ZX; Wang, XX; Xia, Y | 1 |
| Chau, I; Cunningham, D; Watkins, D | 1 |
| Dumontet, C | 1 |
| Archer, CD; Catovsky, D; Chau, I; Cunningham, D; Gill, K; Harries, M; Hill, M; Koh, DM; Norman, AR; Prior, Y; Ross, PJ; Uzzell, M; Wotherspoon, A | 1 |
| Canellos, GP; Fisher, DC; Friedberg, JW; Kim, H; McCauley, M; Miyata, S; Neuberg, D; Takvorian, T | 1 |
| CALABRESI, P; CREASEY, WA; PRUSOFF, H; WELCH, AD | 1 |
| Baetz, T; Belch, A; Couban, S; Crump, M; Ding, K; Iglesias, J; Imrie, K; Meyer, R; Myers, R; Paul, N; Shepherd, L; Yau, J | 1 |
| Bredenfeld, H; Diehl, V; Engert, A; Franklin, J; Fries, S; Josting, A; Mailänder, V; Nogova, L; Oertel, J | 1 |
| Jayabose, S; Ozkaynak, MF | 1 |
| Colovos, C; Emmanouilides, C; Hernandez, L; Pinter-Brown, L; Rosen, P; Schiller, G; Territo, M | 1 |
| Asmar, L; Boehm, KA; Di Bella, N; Flynn, TP; Vellek, MJ; Venkatesh, H | 1 |
| Akpek, G; Badros, A; Bolaños-Meade, J; Fenton, R; Gojo, I; Guo, C; Hakimian, R; Heyman, M; Kiggundu, E; Mannuel, H; Meisenberg, B; Natt, S; Phillips, GL; Rapoport, AP; Ratterree, B; Ruehle, K; Sarkodee-Adoo, C; Takebe, N; Tricot, G; Withers, T | 1 |
| Hajder, J; Marisavljević, D; Ristić, B | 1 |
| Aurer, I; Bogdanić, V; Labar, B; Mrsić, M; Nemet, D; Radman, I; Sertić, D; Zupancić-Salek, S | 1 |
| Ahmed, MM; Desimone, P; Halepota, M; Mohiuddin, M | 1 |
| Bissoli, S; Castoldi, G; Cavazzini, L; Chierichetti, F; Feggi, L; Fraulini, C; Mauro, E; Panareo, S; Rigolin, GM | 1 |
| Crump, M; Keating, A; Kuruvilla, J; Nagy, T; Pintilie, M; Tsang, R | 1 |
| Arnaud, P; Bordier, V; Couturier, J; Decaudin, D; Lantz, O; Marszak, FB; Martin, A; Mathiot, C; Némati, F; Poupon, MF; Santo, Jd; Vincent-Salomon, A | 1 |
| Balzarotti, M; Bramanti, S; Castagna, L; Magagnoli, M; Mazza, R; Nozza, A; Russo, F; Santoro, A; Sarina, B; Siracusano, L; Timofeeva, I; Todisco, E | 1 |
| Aigner, T; Hueber, AJ; Kalden, JR; Kallert, S; Rech, J; Rösler, W; Schulze-Koops, H | 1 |
| Balzarotti, M; Castagna, L; Magagnoli, M; Michieli, M; Morenghi, E; Nozza, A; Pinotti, G; Santoro, A; Sarina, B; Siracusano, L; Spina, M; Tirelli, U | 1 |
| Bartlett, NL; Canellos, GP; Cheson, BD; Friedberg, JW; Johnson, JL; Johnson, KB; Niedzwiecki, D; van Besien, K; Zelenetz, AD | 1 |
| Bredenfeld, H; Diehl, V; Eich, HT; Engert, A; Macann, A; Müller, RP | 1 |
| Balzarotti, M; Capizzuto, R; Castagna, L; Isa, L; Magagnoli, M; Michieli, M; Morenghi, E; Santoro, A; Spina, M; Timofeeva, I; Tirelli, U | 1 |
| Fayad, LE; Goy, A; Hagemeister, F; McLaughlin, P; Neelapu, S; Oki, Y; Pro, B; Romaguera, J; Samaniego, F; Younes, A | 1 |
| Bartlett, NL; Cass, CE; Cheson, B; Cook, JR; Hsi, ED; Johnson, JL; Jones, D; Jung, SH; Lai, R; Mackey, JR; Said, J; Young, JD | 1 |
| Oki, Y; Younes, A | 1 |
| Gerber, HP; Grewal, IS; Kissler, KM; Oflazoglu, E; Sievers, EL | 1 |
| Bernstein, SH; Fisher, RI; Friedberg, JW; Jordan, CT; Kelly, J; Liesveld, J; Marquis, D; Mendler, JH; Rich, L; Rossi, RM; Voci, S | 1 |
| Blehová, Z; Dienstbier, Z; Masopust, J; Sámal, M | 1 |
| Borchmann, P; Diehl, V; Engert, A; Schnell, R | 1 |
| Horning, SJ; Horwitz, SM; Lucas, JB; Sayegh, A | 1 |
| Benoehr, C; Bonadonna, G; Bonfante, V; Bredenfeld, H; Devizzi, L; Diehl, V; Fiedler, F; Pacini, M; Parra, HS; Santoro, A; Tesch, H; Viviani, S | 1 |
| Flamm, M; Garrett, TJ; Heitjan, D; Johnson, SA; Keohan, ML; Lee, RT; Oster, MW; Ruiz, J; Rule, SA; Savage, DG; Tighe, M | 1 |
| Albertini, P; Bendandi, M; Gherlinzoni, F; Piccaluga, PP; Stefoni, V; Tani, M; Tura, S; Zinzani, PL | 1 |
| Eucker, J; Jakob, C; Kaufmann, O; Possinger, K; Schmid, P; Sezer, O | 1 |
| Gandhi, V; Krett, N; Nabhan, C; Rosen, S | 1 |
| Bethe, U; Cornely, OA; Pels, H; Ritzkowsky, A; Seibold, M; Soehngen, D; Toepelt, K | 1 |
| Bechynĕ, M; Buric, L; Dientsbier, Z; Foltýnová, V; Kovaríková, H; Mostecký, H | 1 |
| Buric, L; Dienstbier, Z | 1 |
| Botti, RE; Imperia, PS; Lass, JH; Lazarus, HM; Mack, RJ | 1 |
11 review(s) available for deoxycytidine and Hodgkin Disease
| Article | Year |
|---|---|
[Malignant lymphoma and adult T-cell leukemia-lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Genetic Markers; Genetic Testing; Hodgkin Disease; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Non-Hodgkin; Methylprednisolone; Positron-Emission Tomography; Prednisone; Vincristine | 2014 |
Relapse of Hodgkin lymphoma after autologous transplantation: Time to rethink treatment?
Topics: Adult; Deoxycytidine; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunotherapy; Middle Aged; Neoplasm Recurrence, Local; Risk Factors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2017 |
Salvage regimens for Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Gemcitabine; Hodgkin Disease; Humans; Recurrence; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous | 2008 |
Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy?
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bendamustine Hydrochloride; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Histone Deacetylase Inhibitors; Hodgkin Disease; Humans; Lenalidomide; Nitrogen Mustard Compounds; Rituximab; Thalidomide; Vinblastine; Vinorelbine | 2010 |
Sonographic features of pectoralis muscle necrosis secondary to gemcitabine-induced radiation recall: case report and review of current literature.
Topics: Adult; Antimetabolites, Antineoplastic; Biopsy, Needle; Deoxycytidine; Gemcitabine; Hodgkin Disease; Humans; Male; Necrosis; Pectoralis Muscles; Radiodermatitis; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2010 |
Chemotherapy only for localized Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachial Plexus; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fibrosis; Gemcitabine; Heart; Hodgkin Disease; Humans; Hypothyroidism; Lung; Lymphedema; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Risk Assessment; Secondary Prevention; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 2011 |
Gemcitabine and its combinations in the treatment of malignant lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Gemcitabine; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Random Allocation; Recurrence; Rituximab; Transplantation, Autologous; Treatment Outcome | 2002 |
[The role of gemcitabine in hematology].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Deoxycytidine; DNA Damage; DNA, Neoplasm; Drug Design; Gemcitabine; Hematologic Neoplasms; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Multiple Myeloma; Neoplasm Proteins; Nucleotides; Ribonucleotide Reductases; Salvage Therapy; Treatment Outcome | 2002 |
Current role of gemcitabine in the treatment of Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Hodgkin Disease; Humans; Treatment Outcome | 2008 |
New drugs in the treatment of Hodgkin's disease.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bendamustine Hydrochloride; Deoxycytidine; Drug Therapy; Gemcitabine; Hodgkin Disease; Humans; Idarubicin; Immunotoxins; Nitrogen Mustard Compounds; Vinblastine; Vinorelbine | 1998 |
Gemcitabine in hematologic malignancies.
Topics: Antimetabolites, Antineoplastic; Clinical Trials as Topic; Deoxycytidine; DNA; Gemcitabine; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Tumor Cells, Cultured | 2001 |
35 trial(s) available for deoxycytidine and Hodgkin Disease
| Article | Year |
|---|---|
Tislelizumab with gemcitabine and oxaliplatin in patients with relapsed or refractory classic Hodgkin lymphoma: a multicenter phase II trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Hodgkin Disease; Humans; Oxaliplatin; Prospective Studies; Treatment Outcome | 2023 |
Ifosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Autografts; Child; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Ifosfamide; Male; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Vinorelbine | 2020 |
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Deoxycytidine; Disease-Free Survival; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Recurrence; Transplantation, Autologous | 2020 |
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Cytarabine; Deoxycytidine; Etoposide; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Melphalan; Middle Aged; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Young Adult | 2018 |
Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Canada; Deoxycytidine; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gemcitabine; Hodgkin Disease; Humans; Immunoconjugates; Male; Recurrence; Time Factors; Treatment Outcome; United States | 2018 |
Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Hodgkin Disease; Humans; Ifosfamide; Immunotherapy; Male; Middle Aged; Recurrence; Survival Rate; Vinorelbine | 2019 |
A multicentre phase-II feasibility study evaluating gemcitabine/vinorelbine / prednisolone combination chemotherapy in relapsed / refractory Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Deoxycytidine; Feasibility Studies; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Salvage Therapy; Treatment Outcome; Vinblastine; Vinorelbine; Young Adult | 2013 |
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Deoxycytidine; Drug Administration Schedule; Female; Follow-Up Studies; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Hydroxamic Acids; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Melphalan; Middle Aged; Recurrence; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Vorinostat | 2015 |
B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Combined Modality Therapy; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Recurrence; Remission Induction; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vinorelbine; Young Adult | 2016 |
Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prospective Studies; Transplantation, Autologous; Vinblastine; Vinorelbine; Young Adult | 2016 |
Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Gemcitabine; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Treatment Outcome; Vinblastine; Vinorelbine; Young Adult | 2009 |
Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Transplantation Conditioning; Transplantation, Autologous; Vinblastine; Vinorelbine; Young Adult | 2010 |
Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Double-Blind Method; Doxorubicin; Female; Gemcitabine; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Neoplasm Staging; Polyethylene Glycols; Polymorphism, Single Nucleotide; Receptors, IgG; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine; Young Adult | 2010 |
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Remission Induction; Vinblastine; Young Adult | 2011 |
Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Melphalan; Middle Aged; Recurrence; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Young Adult | 2012 |
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Medication Adherence; Middle Aged; Neoplasm Staging; Patient Dropouts; Prednisone; Prognosis; Recurrence; Remission Induction; Survival Analysis; Vinblastine | 2011 |
Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Radionuclide Imaging; Recurrence; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2013 |
Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Follow-Up Studies; Gemcitabine; Hodgkin Disease; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Male; Methylprednisolone; Middle Aged; Recurrence; Survival Rate | 2003 |
Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Deoxycytidine; Disease Progression; Doxorubicin; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia; Treatment Outcome; Vinblastine | 2003 |
Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Drug Resistance, Neoplasm; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Treatment Outcome | 2003 |
Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination o
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Gemcitabine; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Prednisone; Procarbazine; Vincristine | 2004 |
Pilot study of fixed-infusion rate gemcitabine with Cisplatin and dexamethasone in patients with relapsed or refractory lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Cisplatin; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Hodgkin Disease; Humans; Infusions, Intravenous; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Pilot Projects; Racial Groups; Recurrence | 2004 |
Results of a phase II multicenter trial of single-agent gemcitabine in patients with relapsed or chemotherapy-refractory Hodgkin's lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Marrow Transplantation; Deoxycytidine; Disease Progression; Drug Resistance, Neoplasm; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Middle Aged; Recurrence; Time Factors; Treatment Outcome | 2004 |
Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Deoxycytidine; Dexamethasone; Etoposide; Female; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Salvage Therapy; Secondary Prevention; Survival Analysis; Transplantation, Autologous | 2004 |
Gemcitabine in the treatment of relapsed and refractory Hodgkin's disease.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Croatia; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Risk Assessment; Risk Factors; Survival Rate; Treatment Failure; Treatment Outcome | 2005 |
Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Recurrence; Stem Cell Transplantation; Treatment Outcome; Vinblastine; Vinorelbine | 2007 |
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Gemcitabine; Hodgkin Disease; Humans; Middle Aged; Neutropenia; Patient Selection; Polyethylene Glycols; Salvage Therapy; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 2007 |
Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin's lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin's Lymphoma Stud
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Deoxycytidine; Doxorubicin; Drug Interactions; Etoposide; Female; Gemcitabine; Germany; Hodgkin Disease; Humans; Lung; Male; Middle Aged; Pilot Projects; Prednisone; Procarbazine; Remission Induction; Vincristine | 2008 |
IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Colony-Stimulating Factors; Deoxycytidine; Gemcitabine; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Ifosfamide; Lenograstim; Middle Aged; Recombinant Proteins; Salvage Therapy; Treatment Outcome; Vinblastine; Vinorelbine | 2007 |
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Pain; Rituximab; Survival Analysis; Treatment Outcome | 2008 |
Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Deoxycytidine; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Middle Aged; Proteasome Endopeptidase Complex; Pyrazines | 2008 |
Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study.
Topics: Adult; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Middle Aged | 2000 |
Gemcitabine for relapsed or resistant lymphoma.
Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Hodgkin Disease; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Treatment Outcome | 2000 |
Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients.
Topics: Adult; Antimetabolites, Antineoplastic; Deoxycytidine; Disease-Free Survival; Drug Evaluation; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Middle Aged; Neutropenia; Recurrence; Salvage Therapy; Thrombocytopenia; Treatment Outcome | 2000 |
An in vitro method which assesses corneal epithelial toxicity due to antineoplastic, preservative and antimicrobial agents.
Topics: Adult; Aged; Aminoglycosides; Animals; Antineoplastic Agents; Antiviral Agents; Cells, Cultured; Cornea; Cytarabine; Deoxycytidine; Double-Blind Method; Epithelium; Female; Hodgkin Disease; Humans; Keratitis; Leukemia; Male; Middle Aged; Preservatives, Pharmaceutical; Rabbits; Thymidine; Toxicology | 1989 |
60 other study(ies) available for deoxycytidine and Hodgkin Disease
| Article | Year |
|---|---|
Combination of PD-1 inhibitor with GVD (gemcitabine, vinorelbine, liposomal doxorubicin) versus GVD regimen as second-line therapy for relapsed/refractory classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Management; Doxorubicin; Drug Resistance, Neoplasm; Female; Gemcitabine; Hodgkin Disease; Humans; Immune Checkpoint Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Polyethylene Glycols; Prognosis; Programmed Cell Death 1 Receptor; Recurrence; Retreatment; Treatment Outcome; Vinorelbine; Young Adult | 2022 |
Durable remission for four pediatric patients with high-risk relapsed classical Hodgkin lymphoma treated with brentuximab vedotin plus gemcitabine but without autologous stem cell transplantation: A report from the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Child; Deoxycytidine; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunoconjugates; Neoplasm Recurrence, Local; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous | 2022 |
Gemcitabine, Cisplatin, and Dexamethasone as a Salvage and Mobilization Chemotherapy Before Autologous Stem Cell Transplantation is Effective and Safe Outpatient Regimen in Relapsed and Refractory Hodgkin Lymphoma Patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Outpatients; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous | 2022 |
The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Young Adult | 2020 |
Response rates, long term outcomes and toxicity profile of gemcitabine and vinorelbine based outpatient chemotherapy regimen in primary progressive and relapsed childhood Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Deoxycytidine; Gemcitabine; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Outpatients; Recurrence; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinorelbine | 2020 |
Gemcitabine, cisplatin, and dexamethasone and ifosfamide, carboplatin, and etoposide regimens have similar efficacy as salvage treatment for relapsed/refractory aggressive lymphoma: A retrospectively comparative study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Dexamethasone; Etoposide; Female; Gemcitabine; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Salvage Therapy; Young Adult | 2020 |
Prognostic Analysis of Absolute Lymphocyte and Monocyte Counts after Autologous Stem Cell Transplantation in Children, Adolescents, and Young Adults with Refractory or Relapsed Hodgkin Lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Autografts; Busulfan; Child; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphocyte Count; Male; Melphalan; Recurrence; Retrospective Studies; Young Adult | 2017 |
Brentuximab vedotin-based salvage treatment in Hodgkin's lymphoma.
Topics: Brentuximab Vedotin; Child; Deoxycytidine; Gemcitabine; Hodgkin Disease; Humans; Immunoconjugates; Salvage Therapy; Young Adult | 2018 |
Gemcitabine, vinorelbine and dexamethasone: A safe and effective regimen for treatment of relapsed/refractory hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Middle Aged; Recurrence; Retreatment; Salvage Therapy; Treatment Outcome; Vinorelbine; Young Adult | 2019 |
Gemcitabine induced skin rash.
Topics: Antineoplastic Agents; Child; Deoxycytidine; Exanthema; Gemcitabine; Hodgkin Disease; Humans; Male | 2013 |
A report of a rare case of autoimmune haemolytic anaemia in a patient with Hodgkin's disease in whom routine serology was negative.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Coombs Test; Deoxycytidine; Dexamethasone; Gemcitabine; Hodgkin Disease; Humans; Male; Recurrence | 2014 |
GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Methylprednisolone; Middle Aged; Neutropenia; Recurrence; Retrospective Studies; Survival Analysis; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome | 2014 |
The histone deacetylase inhibitor LBH589 (panobinostat) modulates the crosstalk of lymphocytes with Hodgkin lymphoma cell lines.
Topics: Apoptosis; Blotting, Western; Brentuximab Vedotin; Cell Line, Tumor; Cells, Cultured; Deoxycytidine; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gemcitabine; Histone Deacetylase Inhibitors; Hodgkin Disease; Humans; Hydroxamic Acids; Immunoconjugates; Indoles; Interferon-gamma; Ki-1 Antigen; Lymphocytes; Microscopy, Fluorescence; Panobinostat; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2013 |
Thyroid malignancies in survivors of Hodgkin lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Databases, Factual; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Poisson Distribution; Prednisone; Procarbazine; Radiotherapy Dosage; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Survivors; Thyroid Neoplasms; Vinblastine; Vincristine; Young Adult | 2014 |
[Efficacy and safety evaluation of gemcitabine combined with oxaliplatin in lymphoma patients after failure of multiple chemotherapy regimens].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Remission Induction; Salvage Therapy; Thrombocytopenia; Young Adult | 2014 |
Final analysis of a randomized phase II study with prednisone, vinblastine, doxorubicin, and gemcitabine in patients with early unfavorable Hodgkin lymphoma-PVAG-14 pilot.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Randomized Controlled Trials as Topic; Vinblastine; Young Adult | 2014 |
Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma.
Topics: Adolescent; Adult; Anemia; Antineoplastic Agents; Brentuximab Vedotin; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Drug Hypersensitivity; Female; Gemcitabine; Hodgkin Disease; Humans; Immunoconjugates; Male; Neutropenia; Polyethylene Glycols; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vinorelbine | 2015 |
Salvage therapy with gemcitabine, vinorelbine, and pegylated liposomal doxorubicin for relapsed or refractory pediatric Hodgkin lymphoma. Results of a retrospective series of four children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Polyethylene Glycols; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinblastine; Vinorelbine | 2015 |
[Rituximab combined with second line regimens for treatment of seven relapsed and refractory Hodgkin lymphoma patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cyclophosphamide; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Vinblastine; Vincristine; Vinorelbine; Young Adult | 2015 |
Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma.
Topics: Adult; Brentuximab Vedotin; Deoxycytidine; Female; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunoconjugates; Lung Diseases; Male; Melphalan; Middle Aged; Nausea; Remission Induction; Salvage Therapy; Skin Diseases; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult | 2016 |
Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bendamustine Hydrochloride; Brentuximab Vedotin; Deoxycytidine; Disease Progression; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gemcitabine; Hodgkin Disease; Humans; Immunoconjugates; Male; Middle Aged; Treatment Outcome | 2016 |
Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Drug Resistance, Neoplasm; Female; Gemcitabine; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Recurrence; Retreatment; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult | 2017 |
A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Gemcitabine; Hemoglobins; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome | 2008 |
Coexistence Hodgkin's lymphoma and colonic adenocarcinoma: a case report.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease Progression; Fatal Outcome; Fluorouracil; Gastrointestinal Hemorrhage; Hodgkin Disease; Humans; Immunohistochemistry; Lymph Nodes; Male; Oxaloacetates; Tomography, X-Ray Computed | 2010 |
Bortezomib in combination with IGEV chemotherapy regimen for a primary refractory Hodgkin's lymphoma of bone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Boronic Acids; Bortezomib; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Male; Positron-Emission Tomography; Prednisone; Pyrazines; Vinblastine; Vinorelbine | 2009 |
Intermediate dose gemcitabine-cisplatin combination chemotherapy without treatment delay for cytopenia followed by autografting--a new standard of care in relapsed or refractory Hodgkin lymphoma?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Cisplatin; Combined Modality Therapy; Cytarabine; Deoxycytidine; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Methylprednisolone; Middle Aged; Neutropenia; Recurrence; Retrospective Studies; Salvage Therapy; Transplantation, Autologous; Young Adult | 2009 |
Effects of the anti-VEGF monoclonal antibody bevacizumab in a preclinical model and in patients with refractory and multiple relapsed Hodgkin lymphoma.
Topics: Adult; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cell Growth Processes; Deoxycytidine; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Gemcitabine; Hodgkin Disease; Humans; Immunotherapy; Male; Mice; Mice, SCID; Neoplasm Transplantation; Tumor Burden; Vascular Endothelial Growth Factor A | 2009 |
[Serious cutaneous toxicity following ifosfamide, gemcitabine and vinorelbine therapy in a patient with relapsed Hodgkin lymphoma and ichthyosis].
Topics: Deoxycytidine; Drug Eruptions; Gemcitabine; Hodgkin Disease; Humans; Ichthyosis; Ifosfamide; Male; Middle Aged; Recurrence; Vinblastine; Vinorelbine | 2009 |
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hodgkin Disease; Humans; Male; Mechlorethamine; Melphalan; Organoplatinum Compounds; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Thalidomide; Topotecan; Transplantation, Autologous; Vidarabine; Vinblastine; Vincristine | 2010 |
Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in advanced Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Hodgkin Disease; Humans; Salvage Therapy; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine | 2009 |
Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma.
Topics: Antigens, Neoplasm; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Resistance, Neoplasm; Flow Cytometry; Gemcitabine; Hodgkin Disease; Humans; Immunoenzyme Techniques; Immunotherapy; Prognosis; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured | 2010 |
Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Fluorodeoxyglucose F18; Gemcitabine; Hodgkin Disease; Humans; Positron-Emission Tomography; Recurrence; Research Report; Retrospective Studies; Survival Analysis; Vinblastine; Vinorelbine | 2010 |
Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gemcitabine; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vinorelbine; Young Adult | 2011 |
Classical Hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation.
Topics: Acetylation; Cell Differentiation; Cell Line, Tumor; Deoxycytidine; DNA Methylation; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Hodgkin Disease; Humans; Hydroxamic Acids; Plasma Cells; Polycomb-Group Proteins; Promoter Regions, Genetic; Repressor Proteins | 2011 |
The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors.
Topics: Acetylation; Apoptosis; Apoptosis Regulatory Proteins; Benzamides; Biphenyl Compounds; Boronic Acids; Bortezomib; Cyclin-Dependent Kinase Inhibitor p21; Deoxycytidine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Hodgkin Disease; Humans; Indoles; Lymphoma, Non-Hodgkin; Neoplasm Proteins; Nitrophenols; Piperazines; Protein Processing, Post-Translational; Pyrazines; Pyridines; Pyrroles; Sulfonamides; Tumor Cells, Cultured; X-Linked Inhibitor of Apoptosis Protein | 2011 |
Synergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with chemotherapy.
Topics: Adult; Animals; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Deoxycytidine; Drug Synergism; Exotoxins; Gemcitabine; Hodgkin Disease; Humans; Immunotoxins; Interleukin-2 Receptor alpha Subunit; Mice; Mice, Nude; Plasmacytoma; Tumor Cells, Cultured | 2012 |
High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: a reappraisal of prognostic factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cytarabine; Deoxycytidine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gemcitabine; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methylprednisolone; Middle Aged; Neoplasm Staging; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vinorelbine; Young Adult | 2013 |
[First case in Spain of bacteremia by Methylobacterium thiocyanatum from Hickmann catheter in an immunosuppressed patient with Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Biofilms; Bleomycin; Carmustine; Catheter-Related Infections; Central Venous Catheters; Cisplatin; Cross Infection; Cytarabine; Dacarbazine; Deoxycytidine; Doxorubicin; Drug Resistance, Multiple, Bacterial; Equipment Contamination; Etoposide; Female; Gemcitabine; Gram-Negative Bacterial Infections; Hodgkin Disease; Humans; Immunocompromised Host; Melphalan; Methylobacterium; Prednisone; Ribotyping; Spain; Vinblastine | 2012 |
Acute liver failure secondary to gemcitabine.
Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Hodgkin Disease; Humans; Liver Failure, Acute; Liver Function Tests; Male; Middle Aged; Neoplasm Staging | 2010 |
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fatal Outcome; Female; Gemcitabine; Graft vs Host Disease; Hodgkin Disease; Humans; Ifosfamide; Male; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Recurrence; Reoperation; Rituximab; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Vinorelbine; Young Adult | 2013 |
Treatment strategy based on gemcitabine-containing salvage chemotherapy used with intent to proceed to second stem cell transplant for patients with Hodgkin lymphoma relapsing after a prior autologous transplant.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Recurrence; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Young Adult | 2013 |
[Hodgkin lymphoma with hepatic involvement treated with dexametasone, gemcitabine and cisplatin as a bridge to standard therapy: report of one case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Hodgkin Disease; Humans; Liver Diseases; Middle Aged; Salvage Therapy | 2012 |
Promising long-term outcome of gemcitabine, vinorelbine, liposomal doxorubicin (GVD) in 14-day schedule as salvage regimen for patients with previously heavily treated Hodgkin's lymphoma and aggressive non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Salvage Therapy; Time; Treatment Outcome; Vinblastine; Vinorelbine | 2013 |
Clinical and pharmacological studies with 5-iodo-2'-deoxycytidine.
Topics: Adenocarcinoma; Bromodeoxycytidine; Carcinoma; Carcinoma, Squamous Cell; Deoxycytidine; Hodgkin Disease; Humans; Idoxuridine; Leukemia; Nucleosides | 1963 |
Gemcitabine and vinorelbine as a salvage regimen for relapse in Hodgkin lymphoma after autologous hematopoietic stem cell transplantation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vinorelbine | 2004 |
Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dermatitis; Female; Gemcitabine; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Radionuclide Imaging; Vincristine | 2005 |
Durable local responses with subtherapeutic doses of concurrent radiation and gemcitabine in a patient with refractory Hodgkin's disease.
Topics: Adult; Antimetabolites, Antineoplastic; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Hodgkin Disease; Humans; Male; Treatment Outcome | 2003 |
A case of advanced Hodgkin lymphoma with breast involvement treated with a combination of gemcitabine and pegylated liposomal doxorubicin.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Breast Neoplasms, Male; Deoxycytidine; Doxorubicin; Gemcitabine; Hodgkin Disease; Humans; Male; Radiography; Recurrence | 2005 |
Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cytarabine; Deoxycytidine; Dexamethasone; Disease Progression; Disease-Free Survival; Etoposide; Female; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Prognosis; Recurrence; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2006 |
High efficacy of combined rituximab and gemcitabine on Epstein-Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice.
Topics: Adult; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Deoxycytidine; Epstein-Barr Virus Infections; Female; Gemcitabine; Herpesvirus 4, Human; Hodgkin Disease; Homeodomain Proteins; Humans; Immunoglobulin Heavy Chains; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mice; Mice, Knockout; Mice, SCID; Nucleic Acid Hybridization; Rituximab; Sialic Acid Binding Ig-like Lectin 2; Transplantation, Heterologous; Tumor Cells, Cultured | 2006 |
Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: a monocenter prospective study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Gemcitabine; Hodgkin Disease; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Prospective Studies; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Autologous; Vinblastine; Vinorelbine | 2007 |
Early detection of Richter's transformation: stable disease with dose-reduced gemcitabine and local radiation.
Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Hodgkin Disease; Humans; Radiation-Sensitizing Agents; Treatment Outcome | 2006 |
High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlati
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Doxorubicin; Equilibrative Nucleoside Transporter 1; Female; Gemcitabine; Hodgkin Disease; Humans; Liposomes; Male; Middle Aged; Neoplasm Recurrence, Local; Reed-Sternberg Cells; Survival Rate; Treatment Failure; Vinblastine; Vinorelbine | 2008 |
Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Deoxycytidine; Doxorubicin; Gemcitabine; Hodgkin Disease; Immunoconjugates; Ki-1 Antigen; Mice; Mice, SCID; Neoplasm Transplantation; Oligopeptides; Tubulin Modulators; Vinblastine | 2008 |
Individual changes of DNA catabolite excretion in the course of antitumor therapy of Hodgkin's disease.
Topics: Cyclophosphamide; Deoxycytidine; Deoxyuridine; Hodgkin Disease; Humans; Prednisone; Procarbazine; Thymidine | 1980 |
Gemcitabine is active in relapsed Hodgkin's disease.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Deoxycytidine; Doxorubicin; Gemcitabine; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Tomography, X-Ray Computed; Vinblastine; Vincristine | 1999 |
Achievement of complete remission in refractory Hodgkin's disease with prolonged infusion of gemcitabine.
Topics: Adult; Antimetabolites, Antineoplastic; Bone Marrow; Deoxycytidine; Disease-Free Survival; Drug Evaluation; Gemcitabine; Hodgkin Disease; Humans; Infusions, Intravenous; Recurrence; Remission Induction; Salvage Therapy; Treatment Outcome | 2001 |
A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases, Fungal; Male; Melphalan; Neoplasm Recurrence, Local; Opportunistic Infections; Pneumonia, Bacterial; Pneumonia, Pneumocystis; Prednisone; Procarbazine; Salvage Therapy; Skin; Transplantation, Homologous; Vinblastine; Vincristine | 2001 |
Deoxypyrimidineuria in the course of chemotherapy in M. Hodgkin.
Topics: Cyclophosphamide; Deoxycytidine; Deoxyuridine; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Sex Factors; Splenectomy; Thymidine; Vinblastine; Vincristine | 1976 |
Urine excretion of nucleosides in Hodgkin's disease treated by combined chemotherapy.
Topics: Cyclophosphamide; Deoxycytidine; Deoxyribonucleosides; Deoxyuridine; Drug Therapy, Combination; Hodgkin Disease; Humans; Prednisolone; Thymidine; Time Factors; Vinblastine | 1975 |